BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7177906)

  • 1. Prevention of infection in children with cancer.
    Peter G
    Pediatr Infect Dis; 1982; 1(2):77-81. PubMed ID: 7177906
    [No Abstract]   [Full Text] [Related]  

  • 2. Vancomycin plus gentamicin and cotrimoxazole for prevention of infections in neutropenic cancer patients (a comparative, placebo-controlled pilot study).
    Malarme M; Meunier-Carpentier F; Klastersky J
    Eur J Cancer Clin Oncol; 1981 Dec; 17(12):1315-22. PubMed ID: 7040086
    [No Abstract]   [Full Text] [Related]  

  • 3. Prophylaxis in severe granulocytopenia.
    Thompson EI; Callihan TR; Mauer AM
    Adv Intern Med; 1984; 29():193-214. PubMed ID: 6369925
    [No Abstract]   [Full Text] [Related]  

  • 4. [Co-trimoxazole chemoprophylaxis in immunocompromised patients: analysis of the literature].
    Gava R; Carli M
    G Clin Med; 1989 Jan; 70(1):37-9, 42-6. PubMed ID: 2668092
    [No Abstract]   [Full Text] [Related]  

  • 5. Prophylactic co-trimoxazole and lactobacilli preparation in neutropenic patients.
    Ekert H; Jurk IH; Waters KD; Tiedemann K
    Med Pediatr Oncol; 1980; 8(1):47-51. PubMed ID: 6969348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of infection in leukaemia.
    Gurwith M
    J Antimicrob Chemother; 1978 Jul; 4(4):302-4. PubMed ID: 690029
    [No Abstract]   [Full Text] [Related]  

  • 7. The granulocytopenic patient: another consideration for antimicrobial prophylaxis.
    Otis LL; Terezhalmy GT
    Oral Surg Oral Med Oral Pathol; 1985 Jul; 60(1):125-9. PubMed ID: 3162130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial prophylaxis and treatment in patients with granulocytopenia.
    Med Lett Drugs Ther; 1981 Jun; 23(12):55-6. PubMed ID: 7242457
    [No Abstract]   [Full Text] [Related]  

  • 9. Infection complicating bone marrow transplantation: what are the risks and can they be reduced?
    Rogers TR
    J Hosp Infect; 1982 Jun; 3(2):105-9. PubMed ID: 6181127
    [No Abstract]   [Full Text] [Related]  

  • 10. Failure of trimethoprim/sulfamethoxazole as prophylactic therapy of gram-negative sepsis in pediatric patients with cancer.
    Esquembre C; Ferris J; Verdeguer A; Castel V
    Pediatrics; 1986 Oct; 78(4):719-20. PubMed ID: 3489920
    [No Abstract]   [Full Text] [Related]  

  • 11. Trimethoprim-sulfamethoxazole in the prevention of infection in neutropenic patients. EORTC International Antimicrobial Therapy Project Group.
    J Infect Dis; 1984 Sep; 150(3):372-9. PubMed ID: 6384377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction in mortality from gram-negative sepsis in neutropenic patients receiving trimethoprim/sulfamethoxazole therapy.
    Riben PD; Louie TJ; Lank BA; Kornachuk E; Gurwith MJ; Harding GK; Ronald AR
    Cancer; 1983 May; 51(9):1587-92. PubMed ID: 6339029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Supportive care for children with cancer. Guidelines of the Childrens Cancer Study Group. Use of prophylactic antibiotics.
    Wolff LJ
    Am J Pediatr Hematol Oncol; 1984; 6(3):267-76. PubMed ID: 6393790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-Sulfamethoxazole and bacterial infections during leukemia therapy.
    Young LS
    Ann Intern Med; 1981 Oct; 95(4):508-9. PubMed ID: 7283305
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral trimethoprim/sulfamethoxazole for prevention of bacterial infection during the induction phase of cancer chemotherapy in children.
    Kovatch AL; Wald ER; Albo VC; Prin W; Orlando SJ; Wollman MR; Phebus CK; Shapiro ED
    Pediatrics; 1985 Nov; 76(5):754-60. PubMed ID: 3903647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bacteriologic management of patients with decreased resistance].
    Hendriks WD; Sizoo W; Löwenberg B; Hagenbeek A
    Ned Tijdschr Geneeskd; 1984 Feb; 128(7):305-10. PubMed ID: 6422314
    [No Abstract]   [Full Text] [Related]  

  • 17. Trimethoprim-sulfamethoxazole and trimethoprim alone for prophylaxis of infection in granulocytopenic patients.
    Gurwith M; Truog K; Hinthorn D; Liu C
    Rev Infect Dis; 1982; 4(2):593-601. PubMed ID: 6981175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Carbenicillin-trimethoprim/sulphamethoxazole or carbenicillin-tobramycin as empirical treatment of infection in granulocytopenic patients. A controlled prospective trial (author's transl)].
    Rafecas FJ; Sanz MA; Balaguer H; Santos M; Besalduch J; Martinez J; Marty ML; Gobernado M
    Sangre (Barc); 1981; 26(3):335-46. PubMed ID: 7027489
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic use of gentamicin, cotrimoxazole, and cephalosporins in 10 hospitals in Czechoslovakia.
    Grunt J; Antal M; Krcméry V
    Am J Hosp Pharm; 1986 Jan; 43(1):141-3. PubMed ID: 3485376
    [No Abstract]   [Full Text] [Related]  

  • 20. The choice of antimicrobial drugs.
    Med Lett Drugs Ther; 1988 Mar; 30(762):33-40. PubMed ID: 3258054
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.